US2009215065A1PendingUtilityA1
Atlastin
Est. expirySep 21, 2021(expired)· nominal 20-yr term from priority
A61P 25/08C12N 9/16A61K 38/00A61P 21/00C07K 14/4722G01N 33/6893C12Q 2600/172C07K 14/47C12Q 1/6883C12Q 2600/156Y02A90/10
53
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention relates to methods and compositions of a novel gene and the peptide encoded by the gene. Mutations in the gene, named atlastin, are factors in the disease Hereditary Spastic Paraplegia and related disorders. The present invention will be used for the in the research, diagnosis and treatment of these disabling diseases.
Claims
exact text as granted — not AI-modified1 . A method of identifying subjects who have HSP and those at risk of developing HSP comprising: a) providing nucleic acid from a subject, wherein the nucleic acid comprises a atlastin gene; and b) detecting the presence or absence of one or more variations in the atlastin gene.
Join the waitlist — get patent alerts
Track US2009215065A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.